ConductScience.org, home

Paper36918226

CD47 expression is critical for CAR T-cell survival in vivo.

Beckett AN and 8 others. J Immunother Cancer, 2023. Cited by 33 papers, by iCite.

Cite this record

ConductScience Library. CD47 expression is critical for CAR T-cell survival in vivo. Papers, record 36918226. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36918226

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
CD47 expression is critical for CAR T-cell survival in vivo.
PubMed
Journal
J Immunother Cancer
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
33
iCite
Relative citation ratio, by iCite
2.63
iCite
Revised in PubMed
2026-04-06
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Beckett ANAlex N
2Chockley PPeterhttps://orcid.org/0000-0002-5181-2696
3Pruett-Miller SMShondra M
4Nguyen PPhuong
5Vogel PPeter
6Sheppard HHeather
7Krenciute GGiedrehttps://orcid.org/0000-0003-4335-0644
8Gottschalk SStephenhttps://orcid.org/0000-0003-3991-7468
9DeRenzo CChristopherhttps://orcid.org/0000-0001-6127-4601

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
T-LymphocytesMajor topic
Receptors, Chimeric AntigenMajor topic
Humans
Immunotherapy, Adoptive
CD47 Antigen
Leukocytes, Mononuclear
Cell Survival
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01 CA096832NCI NIH HHSUnited StatesP01CA096832PubMed and NIHNIH RePORTER
P30 CA021765NCI NIH HHSUnited StatesP30CA021765PubMed and NIHNIH RePORTER
R50 CA211481NCI NIH HHSUnited StatesR50CA211481PubMed and NIHNIH RePORTER

Download CSV of grants

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129065481CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.Cancers (Basel)2017https://conductscience.org/library/papers/29065481PubMed
230380386CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma.N Engl J Med2018https://conductscience.org/library/papers/30380386PubMed
333148882MyD88/CD40 signaling retains CAR T cells in a less differentiated state.JCI Insight2020https://conductscience.org/library/papers/33148882PubMed
424006483CD47 plays a critical role in T-cell recruitment by regulation of LFA-1 and VLA-4 integrin adhesive functions.Mol Biol Cell2013https://conductscience.org/library/papers/24006483PubMed
533614914Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer.Mol Ther Oncolytics2021https://conductscience.org/library/papers/33614914PubMed
611156950Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow.FASEB J2001https://conductscience.org/library/papers/11156950PubMed
732019780Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments.Cancer Immunol Res2020https://conductscience.org/library/papers/32019780PubMed
832421049Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure-function.Antib Ther2020https://conductscience.org/library/papers/32421049PubMed
915699129Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system.J Immunol2005https://conductscience.org/library/papers/15699129PubMed
1010358145CD47 signals T cell death.J Immunol1999https://conductscience.org/library/papers/10358145PubMed
1117299405Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma.Mol Ther2007https://conductscience.org/library/papers/17299405PubMed
1229552579Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma.Mol Ther Methods Clin Dev2018https://conductscience.org/library/papers/29552579PubMed
1332728609Route of 41BB/41BBL Costimulation Determines Effector Function of B7-H3-CAR.CD28ζ T Cells.Mol Ther Oncolytics2020https://conductscience.org/library/papers/32728609PubMed
1411514609CD47 (integrin-associated protein) engagement of dendritic cell and macrophage counterreceptors is required to prevent the clearance of donor lymphohematopoietic cells.J Exp Med2001https://conductscience.org/library/papers/11514609PubMed
1528807568Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains.Mol Ther2017https://conductscience.org/library/papers/28807568PubMed
1623722425Engineered SIRPα variants as immunotherapeutic adjuvants to anticancer antibodies.Science2013https://conductscience.org/library/papers/23722425PubMed
1710856220Role of CD47 as a marker of self on red blood cells.Science2000https://conductscience.org/library/papers/10856220PubMed
189548474T cell stimulation via CD47: agonistic and antagonistic effects of CD47 monoclonal antibody 1/1A4.J Immunol1997https://conductscience.org/library/papers/9548474PubMed
1934257155Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance.Proc Natl Acad Sci U S A2021https://conductscience.org/library/papers/34257155PubMed
2031462760Phagocytosis checkpoints as new targets for cancer immunotherapy.Nat Rev Cancer2019https://conductscience.org/library/papers/31462760PubMed

See all 49 referencesDownload CSV of references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.

PMIDTitleJournalYearIn PapersSource
42643739Therapeutic biologics interference in serological and pre-transfusion testing.Front Immunol2026https://conductscience.org/library/papers/42643739PubMed
42607363Tumor size limits macrophage activation and imaging response to CD47 blockade in osteosarcoma.Biomed Pharmacother2026https://conductscience.org/library/papers/42607363PubMed
42500710Targeting the CD47-SIRPα phagocytic checkpoint in cancer: Biology, translational opportunities, and next-generation therapeutic strategies.Smart Mol2026https://conductscience.org/library/papers/42500710PubMed
42004948Erythrocyte membrane-liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells.Front Immunol2026https://conductscience.org/library/papers/42004948PubMed
41627173LRRC15-CAR T Cells for the Treatment of Osteosarcoma.Clin Cancer Res2026https://conductscience.org/library/papers/41627173PubMed
41511303CAR-NK Engineering to Overcome TME Barriers.Cells2025https://conductscience.org/library/papers/41511303PubMed
41485186Emerging strategies to reduce the side effects of CAR-T cell therapy: focusing on gene editing and nanotechnology.Clin Transl Oncol2026https://conductscience.org/library/papers/41485186PubMed
41428241CD47 signaling in aging and age-related diseases: mechanisms, challenges, and therapeutic opportunities.Biogerontology2025https://conductscience.org/library/papers/41428241PubMed
41419929Next-generation CAR-T cells design: leveraging tumor features for enhanced efficacy.Mol Cancer2025https://conductscience.org/library/papers/41419929PubMed
41354926Improving CAR T cell therapy against malignancies through gene knock-down/out strategies: a systematic review.Cancer Cell Int2025https://conductscience.org/library/papers/41354926PubMed
41276863Harnessing the potential of gene editing technology for CAR-T cell therapy of solid tumors.Inflamm Regen2025https://conductscience.org/library/papers/41276863PubMed
41249483Thrombospondin-1-CD47 signaling contributes to the development of T cell exhaustion in cancer.Nat Immunol2025https://conductscience.org/library/papers/41249483PubMed
41084874Allogeneic CAR-T cell therapy in autoimmune diseases.Immunotherapy2025https://conductscience.org/library/papers/41084874PubMed
41019041Arsenic sulfide enhances the therapeutic effect of hepatocellular carcinoma immunotherapy through STAT3-THBS1/CD47 pathway.Front Immunol2025https://conductscience.org/library/papers/41019041PubMed
40005909Mesenchymal Stem Cells with Simultaneous Overexpression of GPX3 and CD47 for the Treatment of Drug-Induced Acute Liver Injury.Vet Sci2025https://conductscience.org/library/papers/40005909PubMed
39906740A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells.Front Immunol2024https://conductscience.org/library/papers/39906740PubMed
39624236Combining the induced pluripotent stem cell (iPSC) technology with chimeric antigen receptor (CAR)-based immunotherapy: recent advances, challenges, and future prospects.Front Cell Dev Biol2024https://conductscience.org/library/papers/39624236PubMed
39584189Dual CD47 and PD-L1 blockade elicits anti-tumor immunity by intratumoral CD8+ T cells.Clin Transl Immunology2024https://conductscience.org/library/papers/39584189PubMed
39521782Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker.Nat Commun2024https://conductscience.org/library/papers/39521782PubMed
39382819Developing CAR T-Cell Therapies for Pediatric Solid Tumors.Paediatr Drugs2025https://conductscience.org/library/papers/39382819PubMed

See all 28 cited byDownload CSV of cited by

Genes25

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AAVS117PubTator's text mininghttps://conductscience.org/library/genes/17NCBI Gene
CARS1833PubTator's text mininghttps://conductscience.org/library/genes/833NCBI Gene
CCR71236PubTator's text mininghttps://conductscience.org/library/genes/1236NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD47961PubTator's text mininghttps://conductscience.org/library/genes/961NCBI Gene
CD5921PubTator's text mininghttps://conductscience.org/library/genes/921NCBI Gene
CD7924PubTator's text mininghttps://conductscience.org/library/genes/924NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
EPHA21969PubTator's text mininghttps://conductscience.org/library/genes/1969NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
HAVCR284868PubTator's text mininghttps://conductscience.org/library/genes/84868NCBI Gene
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
IL153600PubTator's text mininghttps://conductscience.org/library/genes/3600NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL73574PubTator's text mininghttps://conductscience.org/library/genes/3574NCBI Gene
LAG33902PubTator's text mininghttps://conductscience.org/library/genes/3902NCBI Gene

See all 25 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36918226

GET https://conductscience.org/api/papers/v1/36918226/references?page=2